ASCO 2024: Most Interesting Data Upcoming at the Conference
It's time to dive into the sea of ASCO abstracts and pick out what is most interesting
Guess what, reader? Your sponsorship could go right here at the very top of the next Big Pharma Sharma post.
A sponsored post is 100% accessible to all subscriber levels and gets your brand, product, or service in front of my audience of BioPharma Industry decision-makers.
If you or your company is interested in becoming a Big Pharma Sharma sponsor, please reach out to me here or on my socials. Click the button below to learn how you can sponsor the next edition of Big Pharma Sharma.
ASCO is right around the corner, taking place from June 2-6 in Chicago. As has become tradition, I've combed through the abstracts and selected the ones that have piqued my interest the most across cell therapy, immuno-oncology, and targeted therapy modalities. I'll share some initial thoughts based on just the title and context about the specific studies in focus. Full abstracts for the non-late breakers are set to be released on May 23rd. Let's dig in!
Cell Therapy Abstracts
